The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Functional reprogramming of regulatory T cells in the absence of Foxp3
Open accessAbstract
Regulatory T cells (T reg cells) deficient in the transcription factor Foxp3 lack suppressor function and manifest an effector T (T eff) cell-like phenotype. We demonstrate that Foxp3 deficiency dysregulates metabolic checkpoint kinase mammalian target of rapamycin (mTOR) complex 2 (mTORC2) signaling and gives rise to augmented aerobic glycolysis and oxidative phosphorylation. Specific deletion of the mTORC2 adaptor gene Rictor in Foxp3-deficient T reg cells ameliorated disease in a Foxo1 transcription factor-dependent manner. Rictor deficiency re-established a subset of T reg cell genetic circuits and suppressed the T eff cell-like glycolytic and respiratory programs, which contributed to immune dysregulation. Treatment of T reg cells from patients with FOXP3 deficiency with mTOR inhibitors similarly antagonized their T eff cell-like program and restored suppressive function. Thus, regulatory function can be re-established in Foxp3-deficient T reg cells by targeting their metabolic pathways, providing opportunities to restore tolerance in T reg cell disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AKT/mTOR/HIF1α signaling has been suggested to play critical roles in promoting glycolysis and lactate production and thus in the “metabolic reprogramming” of cancer cells24–28.”
From RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression (2020) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
AKT/PKB Signaling: Navigating the Network
Manning, B. D., & Toker, A. (2017) · Cell · doi:10.1016/j.cell.2017.04.001 · Cited by 3,772
Regulatory T cells: mechanisms of differentiation and function
Josefowicz, S. Z., Lu, L.-F., & Rudensky, A. Y. (2012) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141623 · Cited by 2,866
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation
Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140
Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003613 · Cited by 2,091
Shi, L. Z., Wang, R., Huang, G., Vogel, P., Neale, G., Green, D. R., & Chi, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110278 · Cited by 1,803
Transcriptional control of effector and memory CD8+ T cell differentiation
Kaech, S. M., & Cui, W. (2012) · Nature Reviews Immunology · doi:10.1038/nri3307 · Cited by 1,628
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
Bock, K. D., Γεωργιάδου, Μ., Schoors, S., Kuchnio, A., Wong, B. W., Cantelmo, A. R., Quaegebeur, A., Ghesquière, B., Cauwenberghs, S., Eelen, G., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.037 · Cited by 1,591
Self-citationSeddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512
Cited by
Sorted by citations
Li, C., Jiang, P., Wei, S., Xu, X., & Wang, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01234-1 · Cited by 972
Chemokines and the immune response to cancer
Ozga, A. J., Chow, M. T., & Luster, A. D. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.012 · Cited by 884
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 811
Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
Fugger, L. H., Jensen, L. T., & Rossjohn, J. (2020) · Cell · doi:10.1016/j.cell.2020.03.007 · Cited by 415
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
Saleh, R., & Elkord, E. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.022 · Cited by 372
Weng, M.-L., Chen, W.-K., Chen, X.-Y., Lu, H., Sun, Z.-R., Yu, Q., Sun, P.-F., Xu, Y.-J., Zhu, M.-M., Jiang, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15795-8 · Cited by 242
RetractedRegulatory T Cells: the Many Faces of Foxp3
Georgiev, P., Charbonnier, L., & Chatila, T. A. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00684-7 · Cited by 253
Self-citationTreg cells in health and autoimmune diseases: New insights from single cell analysis
Scheinecker, C., Göschl, L., & Bonelli, M. M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102376 · Cited by 224
Sumida, T. S., Cheru, N. T., & Hafler, D. A. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-00994-x · Cited by 229
Metabolic Control of Treg Cell Stability, Plasticity, and Tissue-Specific Heterogeneity
Shi, H., & Chi, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02716 · Cited by 211
mTOR signaling at the crossroads of environmental signals and T‐cell fate decisions
Huang, H., Long, L., Zhou, P., Chapman, N. M., & Chi, H. (2020) · Immunological Reviews · doi:10.1111/imr.12845 · Cited by 193
Foxp3 Post-translational Modifications and Treg Suppressive Activity
Deng, G., Song, X., Fujimoto, S., Piccirillo, C. A., Nagai, Y., & Greene, M. I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02486 · Cited by 171
Regulatory T Cell-Derived TGF-β1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity
Turner, J., Victor, E. S., Wang, S., Rivas, M. N., Abdel-Gadir, A., Harb, H., Cui, Y., Fanny, M., Charbonnier, L., Fong, J. J. H., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.002 · Cited by 147
Self-citationTryptophan‐derived serotonin‐kynurenine balance in immune activation and intestinal inflammation
Haq, S., Grondin, J. A., & Khan, W. I. (2021) · The FASEB Journal · doi:10.1096/fj.202100702r · Cited by 144
Regulatory T cells in the face of the intestinal microbiota
Ramanan, D., Pratama, A., Zhu, Y., Venezia, O., Sassone-Corsi, M., Chowdhary, K., Galván-Peña, S., Sefik, E., Brown, C., Gélineau, A., et al. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00890-w · Cited by 126
Li, X., Zhang, Z., Zabed, H. M., Yun, J., Zhang, G., & Qi, X. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000461 · Cited by 129
A regulatory T cell Notch4–GDF15 axis licenses tissue inflammation in asthma
Harb, H., Victor, E. S., Crestani, E., Benamar, M., Massoud, A. H., Cui, Y., Charbonnier, L., Arbag, S. N., Barış, S., Cunnigham, A., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0777-3 · Cited by 124
Self-citationHuman FOXP3 and tumour microenvironment
Wang, J., Gong, R., Zhao, C., Lei, K., Sun, X., & Ren, H. (2022) · Immunology · doi:10.1111/imm.13520 · Cited by 131
van der Veeken, J., Glasner, A., Zhong, Y., Hu, W., Wang, Z.-M., Bou-Puerto, R., Charbonnier, L., Chatila, T. A., Leslie, C. S., & Rudensky, A. Y. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.010 · Cited by 112
Self-citationKim, D., Nguyen, Q. T., Lee, J., Lee, S. H., Janocha, A. J., Kim, S., Le, H. T., Dvorina, N., Weiss, K., Cameron, M. J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.002 · Cited by 116
Regulatory T cell and macrophage crosstalk in acute lung injury: future perspectives
Guan, T., Zhou, X., Zhou, W., & Lin, H. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01310-7 · Cited by 108
Toward an optimized process for clinical manufacturing of CAR-treg cell therapy
Fritsche, E., Volk, H.-D., Reinke, P., & Abou-El-Enein, M. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.009 · Cited by 97
van der Veeken, J., Campbell, C., Pritykin, Y., Schizas, M., Verter, J. G., Hu, W., Wang, Z.-M., Matheis, F., Mucida, D., Charbonnier, L., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.05.010 · Cited by 95
Self-citationKim, M. J., Kim, K., Park, H. J., Kim, G.-R., Hong, K. H., Oh, J. H., Son, J., Park, D. J., Kim, D., Choi, J.-M., et al. (2023) · Nature Immunology · doi:10.1038/s41590-022-01373-1 · Cited by 90
Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion
Lamarche, C., Ward‐Hartstonge, K. A., Tian, M., Lin, D. T. S., Huang, Q. B., Brown, A., Edwards, K., Novakovsky, G., Qi, C. N., Kobor, M. S., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219086120 · Cited by 87
Treatment with rapamycin can restore regulatory T-cell function in IPEX patients
Passerini, L., Barzaghi, F., Curto, R., Sartirana, C., Barera, G., Tucci, F., Albarello, L., Mariani, A., Testoni, P. A., Bazzigaluppi, E., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.11.043 · Cited by 74
Regulatory T cells as metabolic sensors
de Candia, P., Procaccini, C., Russo, C., Lepore, M. T., & Matarese, G. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.006 · Cited by 71
Nezhad, M. S., Seifalian, A. M., Bagheri, N., Yaghoubi, S., Karimi, M. H., & Adbollahpour-Alitappeh, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603237 · Cited by 72
Pulanco, M. C., Madsen, A. T., Tanwar, A., Corrigan, D. T., & Zang, X. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01019-8 · Cited by 69
Regulatory T cell is critical for interleukin-33-mediated neuroprotection against stroke
Liu, X., Hu, R., Pei, L., Si, P., Wang, C., Tian, X., Wang, X., Liu, H., Wang, B., Xia, Z., et al. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113233 · Cited by 68
Zemmour, D., Charbonnier, L., Léon, J., Six, E. M., Keleş, S., Delville, M., Benamar, M., Barış, S., Zuber, J., Chen, K., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00910-8 · Cited by 65
Self-citationIPEX syndrome: genetics and treatment options
Ben-Skowronek, I. (2021) · Genes · doi:10.3390/genes12030323 · Cited by 64
Metabolism Characteristics of Th17 and Regulatory T Cells in Autoimmune Diseases
Qin, Y., Gao, C., & Luo, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.828191 · Cited by 68
IPEX syndrome from diagnosis to cure, learning along the way
Bacchetta, R., & Roncarolo, M. G. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.11.021 · Cited by 60
Ohno, R., & Nakamura, A. (2024) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2024.152479 · Cited by 64
Pancreatic islet transplantation: current advances and challenges
Wang, Q., Huang, Y., Liu, L., Zhao, X., Sun, Y., Mao, X., & Li, S.-W. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1391504 · Cited by 63
Sato, Y., Passerini, L., Piening, B., Uyeda, M. J., Goodwin, M., Gregori, S., Snyder, M. P., Bertaina, A., Roncarolo, M., & Bacchetta, R. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1214 · Cited by 56
Treg: A Promising Immunotherapeutic Target in Oral Diseases
Zhang, Y., Guo, J., & Jia, R. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.667862 · Cited by 55
IPEX Syndrome: Improved Knowledge of Immune Pathogenesis Empowers Diagnosis
Barzaghi, F., & Passerini, L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.612760 · Cited by 54
Taves, M. D., Otsuka, S., Taylor, M. A., Donahue, K. M., Meyer, T. J., Cam, M. C., & Ashwell, J. D. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164599 · Cited by 52
FoxP3 associates with enhancer-promoter loops to regulate Treg-specific gene expressionPreprint
Ramírez, R. N., Chowdhary, K., Léon, J., Mathis, D. J., & Benoist, C. O. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.12.468430 · Cited by 50
Foxp3 confers long-term efficacy of chimeric antigen receptor-T cells via metabolic reprogramming
Niu, C., Wei, H., Pan, X., Wang, Y., Song, H., Li, C., Qie, J., Qian, J., Mo, S., Zheng, W., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.04.008 · Cited by 49
Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., & Xie, Z. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00689-6 · Cited by 52
T cell-specific deletion of Pgam1 reveals a critical role for glycolysis in T cell responses
Toriyama, K., Kuwahara, M., Kondoh, H., Mikawa, T., Takemori, N., Konishi, A., Yorozuya, T., Yamada, T., Soga, T., Shiraishi, A., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01122-w · Cited by 51
The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies
Vijayanathan, Y., & Ho, I. A. W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020669 · Cited by 47
Yano, H., Koga, K., Sato, T., Shinohara, T., Iriguchi, S., Matsuda, A., Nakazono, K., Shioiri, M., Miyake, Y., Kassai, Y., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.05.004 · Cited by 44
Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis
Domvri, K., Petanidis, S., Zarogoulidis, P., Anestakis, D., Tsavlis, D., Bai, C., Huang, H., Freitag, L., Hohenforst‐Schmidt, W., Porpodis, Κ., et al. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108620 · Cited by 43
Mechanisms of TREG cell adaptation to inflammation
Alvarez, F., Al-Aubodah, T.-A., Yang, Y. H., & Piccirillo, C. A. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1mr0120-196r · Cited by 41
Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation
Narula, M., Lakshmanan, U., Borna, Š., Schulze, J., Holmes, T. H., Harre, N., Kirkey, M., Ramachandran, A., Tagi, V. M., Barzaghi, F., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.09.013 · Cited by 39
Impact of Lipid Metabolism on Antitumor Immune Response
Mabrouk, N., Lecoeur, B., Bettaı̈eb, A., Paul, C., & Végran, F. (2022) · Cancers · doi:10.3390/cancers14071850 · Cited by 36
Metabolic profiles of regulatory T cells in the tumour microenvironment
Rao, D., Verburg, F., Renner, K., Peeper, D. S., Lacroix, R., & Blank, C. U. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02881-z · Cited by 43
Benamar, M., Chen, Q., Chou, J., Julé, A. M., Boudra, R., Contini, P., Crestani, E., Lai, P. S., Wang, M.-Y., Fong, J., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci163235 · Cited by 27
Self-citationCurrent perspectives of osteoclastogenesis through estrogen modulated immune cell cytokines
Uehara, I. A., Soldi, L. R., & Silva, M. J. B. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117921 · Cited by 34
A Stk4-Foxp3–NF-κB p65 transcriptional complex promotes T reg cell activation and homeostasis
Cui, Y., Benamar, M., Schmitz‐Abe, K., Krishnan, V. P., Chen, Q., Jugder, B., Fatou, B., Fong, J. J. H., Zhong, Y., Mehta, S., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl8357 · Cited by 32
Self-citationAn integrated transcription factor framework for Treg identity and diversity
Chowdhary, K., Léon, J., Ramanan, D., Mathis, D., & Benoist, C. O. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2411301121 · Cited by 31
Borna, Š., Lee, E., Nideffer, J., Ramachandran, A., Wang, B., Baker, J. B., Mavers, M., Lakshmanan, U., Narula, M., Garrett, A. K.-H., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg6822 · Cited by 31
Transcriptional regulation of Treg homeostasis and functional specification
Wang, K., & Fu, W. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03534-7 · Cited by 34
Huang, Q., Liu, X., Zhang, Y., Huang, J., Li, D., & Li, B. (2020) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.011 · Cited by 30
Regulatory T cells in allergic inflammation
Benamar, M., Chen, Q., Martínez‐Blanco, M., & Chatila, T. A. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101847 · Cited by 31
Self-citationCell‐intrinsic and ‐extrinsic roles of miRNAs in regulating T cell immunity
Cho, S., Dong, J., & Lu, L. (2021) · Immunological Reviews · doi:10.1111/imr.13029 · Cited by 29
The ‘Treg paradox’ in inflammatory arthritis
Schnell, J. T., Briviesca, R. L., Kim, T., Charbonnier, L., Henderson, L. A., van Wijk, F., & Nigrovic, P. A. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01190-w · Cited by 27
Self-citationRegulatory T Cell Stability and Migration Are Dependent on mTOR
Vallion, R., Divoux, J., Glauzy, S., Ronin, É., Lombardi, Y., di Ricco, M. L., Grégoire, S., Nemazanyy, I., Durand, A., Fradin, D., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901480 · Cited by 28
Brown, C. Y., Sadlon, T. J., Hope, C. M., Wong, Y. Y., Wong, S. W., Liu, N., Withers, H., Brown, K. A., Bandara, V., Gundsambuu, B., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01269 · Cited by 25
Duan, F., Li, Y.-S., Hu, T., Pan, X.-Q., Ma, F., Feng, Y., Qiu, S.-Q., & Zheng, Y. (2022) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(22)60168-7 · Cited by 24
Metabolic control of T cells in autoimmunity
Kono, M., Yoshida, N., & Tsokos, G. C. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000685 · Cited by 23
Protein kinase C: release from quarantine by mTORC2
Baffi, T. R., & Newton, A. C. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.03.003 · Cited by 25
Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis
Huang, C., Shen, Y., Shen, M., Fan, X., Men, R., Ye, T., & Yang, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.726128 · Cited by 22
Regulation of Treg Cell Metabolism and Function in Non-Lymphoid Tissues
Yang, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909705 · Cited by 22
Kolben, T., Mannewitz, M., Perleberg, C., Schnell, K., Anz, D., Hahn, L., Meister, S., Schmoeckel, E., Burges, A., Czogalla, B., et al. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00708-2 · Cited by 22
The role of FOXP3 in non-small cell lung cancer and its therapeutic potentials
Peng, J., Yang, S., Ng, C. S. H., & Chen, G. G. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108333 · Cited by 21
Léon, J., Chowdhary, K., Zhang, W., Ramírez, R. N., André‐Schmutz, I., Hur, S., Mathis, D. J., & Benoist, C. O. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113018 · Cited by 21
Metabolic regulation of regulatory T cells: mechanisms, heterogeneity, and implications in disease
Getachew, F., Hu, J., & Benamar, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1729690 · Cited by 22
Clinical and diagnostic potential of regulatory T cell markers: From bench to bedside
Haddadi, M. H., & Negahdari, B. (2021) · Transplant Immunology · doi:10.1016/j.trim.2021.101518 · Cited by 20
Inhibition of FOXP3 by stapled alpha-helical peptides dampens regulatory T cell function
Hawley, K. M., Eclov, R. J., Schnorenberg, M. R., Tian, Y. P., Shah, R. N., Thomas-Toth, A. T., Fefferman, M. L., Bird, G. H., Walensky, L. D., Tirrell, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209044119 · Cited by 19
Jäger, C., Dimitrova, P. D., Sun, Q., Tennebroek, J., Marchiori, E., Jaritz, M., Rauschmeier, R., Estivill, G., Obenauf, A. C., Busslinger, M., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adr7057 · Cited by 22
Yu, F., Zhao, X., Li, M., & Meng, M. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01838-0 · Cited by 18
Self-citationA Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives
Han, Z., Ma, K., Tao, H., Liu, H., Zhang, J., Sai, X., Li, Y., Chi, M., Nian, Q., Song, L., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.826732 · Cited by 21
Distinct metabolic pathways mediate regulatory T cell differentiation and function
Hashimoto, H., McCallion, O., Kempkes, R. W. M., Hester, J., & Issa, F. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.04.011 · Cited by 16
T lymphocytes in IgA nephropathy (Review)
Tang, Y., He, H., Hu, P., & Xu, X. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8673 · Cited by 16
FOXP3 deficiency, from the mechanisms of the disease to curative strategies
Borna, Š., Meffre, E., & Bacchetta, R. (2023) · Immunological Reviews · doi:10.1111/imr.13289 · Cited by 17
Durand, A., Bonilla, N., Level, T., Ginestet, Z., Lombès, A., Guichard, V., Germain, M., Jacques, S., Letourneur, F., Cruzeiro, M. D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45984-8 · Cited by 20
Cheng, Y., Li, X., Dai, Y., Dong, Y., Yang, X., & Wang, J. (2021) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2021.32.e30 · Cited by 14
Metabolic Optimisation of Regulatory T Cells in Transplantation
Atif, M., Mohr, A., Conti, F., Scatton, O., Gorochov, G., & Miyara, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02005 · Cited by 16
Saksida, T., Jevtić, B., Djedović, N., Miljković, D. M., & Stojanović, I. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7999 · Cited by 14
Autoimmunity and immunodeficiency
Hoyos‐Bachiloglu, R., & Chou, J. S. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000688 · Cited by 13
Yu, Y., Jin, Q., Mi, Y., Liu, J., Liu, Z., Wang, S., Liu, Z., Yang, P., & Zheng, P. (2021) · Journal of Innate Immunity · doi:10.1159/000515332 · Cited by 12
Pieren, D. K. J., Smits, N. A. M., Imholz, S., Nagarajah, B., van Oostrom, C. T., Brandt, R. M. C., Vermeij, W. P., Dollé, M. E. T., & Guichelaar, T. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.667193 · Cited by 12
FOXP3 (in)stability and cancer immunotherapy
Mortezaee, K. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156589 · Cited by 11
Regulatory T-cells and IL-5 mediate pain outcomes in a preclinical model of chronic muscle pain
Lenert, M. E., Szabo-Pardi, T. A., & Burton, M. D. (2022) · Molecular Pain · doi:10.1177/17448069221110691 · Cited by 12
Wang, H., Luo, F., Shao, X., Gao, Y. Y., Jiang, N., Jia, C., Li, H., & Chen, R. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c00809 · Cited by 11
Huang, M., & Dong, J. (2021) · Journal of Immunology Research · doi:10.1155/2021/8816055 · Cited by 11
Thymic origins of autoimmunity—lessons from inborn errors of immunity
Bacchetta, R., & Weinberg, K. I. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-020-00835-8 · Cited by 10
Lamarche, C., Novakovsky, G., Qi, C. N., Weber, E. W., Mackall, C. L., & Levings, M. K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.27.175158 · Cited by 10
mTORC2 contributes to systemic autoimmunity
Zhou, X., Qi, H., Li, M., Li, Y., Zhu, X., Amin, S., Alexander, M. P., Diadhiou, C. M. M., Davidson, A., & Zeng, H. (2022) · Immunology · doi:10.1111/imm.13594 · Cited by 9
Self-citationGao, A., Wu, R., Mu, Y., Jin, R., Jiang, S., Gao, C., Li, X., & Wang, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565133 · Cited by 9
Inborn errors of regulatory T-cell differentiation and function
Öktelik, F. B., Luo, Y., Benamar, M., & Chatila, T. A. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.07.001 · Cited by 9
Self-citationTranscription factor defects in inborn errors of immunity with atopy
Vaseghi‐Shanjani, M., Yousefi, P., Sharma, M., Samra, S., Sifuentes, E., Turvey, S. E., & Biggs, C. M. (2023) · Frontiers in Allergy · doi:10.3389/falgy.2023.1237852 · Cited by 9
Li, Y., Chen, Y., Mao, S., Kaundal, R. K., Jing, Z., Chen, Q., Wang, X., Xia, J., Liu, D., Sun, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15836-2 · Cited by 9
Bozkurt, H. B., Catak, F. B., Sahin, A., Gungoren, E. Y., Karaaslan, H. B. G., Yakıcı, N., Altunbaş, M. Y., Çatak, M. C., Can, S., Amirov, R., et al. (2024) · Journal of Clinical Immunology · doi:10.1007/s10875-024-01791-w · Cited by 8
Self-citationCarnitine Palmitoyl Transferase Deficiency in a University Immunology Practice
Bax, K., Isackson, P. J., Moore, M., & Ambrus, J. L. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-0879-9 · Cited by 8
Metadata
- Authors
- Charbonnier, L.-M., Cui, Y., Stephen-Victor, E., Harb, H., Lopez, D., Bleesing, J. J., Garcia-Lloret, M. I., Chen, K., Ozen, A., Carmeliet, P., Li, M. O., Pellegrini, M., & Chatila, T. A.
- Affiliations
- Boston Children's Hospital (US)
- University of California, Los Angeles (US)
- Cincinnati Children's Hospital Medical Center (US)
- University of Utah (US)
- Marmara University (TR)
- VIB-KU Leuven Center for Cancer Biology (BE)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Chatila, Talal A.
- ORCID
- Venue
- Nature Immunology
- Published
- 2019-08-05
- Volume
- 20
- Issue
- 9
- Pages
- 1208-1219
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC6707855
- OpenAlex
- W2966678440
- Cited by
- 145
- References
- 55
- Citations by year
- 2026: 14 · 2025: 12 · 2024: 14 · 2023: 16 · 2022: 26 · 2021: 24 · 2020: 32 · 2019: 7
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Dspace Repository (Marmara Üniversitesi) (submittedVersion, other-oa)
- Lirias (KU Leuven) (submittedVersion)
- Dspace Repository (Marmara Üniversitesi) (submittedVersion)
- Funders
- National Institutes of Health (5r01ai085090-10)
- National Cancer Institute (P30CA008748, P30CA016042)
- National Institute of Allergy and Infectious Diseases (R01-AI-085090, R01AI102888, R01AI065617)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034854)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- regulatory T cells, mTORC2 signaling, Rictor, aerobic glycolysis, oxidative phosphorylation, FOXO1, mTOR inhibitors, immune tolerance, immune dysregulation
- MeSH terms
- Mechanistic Target of Rapamycin Complex 2, Rapamycin-Insensitive Companion of mTOR Protein, Animals, Cells, Cultured, Female, Gene Expression Regulation, Glycolysis, Humans, Male, Mice, Inbred C57BL, Oxidative Phosphorylation, Signal Transduction, Mice, Knockout, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review